News
Centre of the month: March 2023
Bradford was chosen for getting back up-to-date with their follow-ups. A message from Bradford: I think COVID and staffing had a major impact overall on this study and we had to take a step back for some time. When Sr Johnson (retired) and latterly myself became the...
Centre of the month: February 2023
Aneurin Bevan Health Board was selected for their continued efforts for keeping their patient follow-ups up to date. A message from Aneurin Bevan: I feel, the reason BADBIR has been a success at ABUHB is due to open communication and mutual trust throughout our team....
Centre of the month: January 2023
Norfolk and Norwich University Hospital was selected for their continued hard work on following up BADBIR participants. A message from Norwich: In Norwich we are fortunate in having a cohesive team of doctors and nurses who support clinical research and all help with...
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR
BJD, 2023.Alabas OA, Mason KJ, Yiu ZZN, Hampton PJ, Reynolds NJ, Owen CM, Bewley A, Laws PM, Warren RB, Lunt M, Smith CH, Griffiths CEM; BADBIR Study Group.Read publication: BJD Related Contact Us Tel: +44 (0)161 306 1896 Email:...
BADBIR Team at the BDNG 31st Annual Conference
The BADBIR team will be present in Harrogate for the BDNG Annual Conference 20th - 22nd September.We hope to see you there! Related Contact Us Tel: +44 (0)161 306 1896 Email: badbir@manchester.ac.uk Find Us The University of...
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis
JAMA Dermatol, 2022.Yiu ZZN, Becher G, Kirby B, Laws P, Reynolds NJ, Smith CH, Warren RB, Griffiths CEM; BADBIR Study Group.Read publication: JAMA Dermatol Related Contact Us Tel: +44 (0)161 306 1896 Email: badbir@manchester.ac.uk Find Us...
Associations between psoriatic arthritis and mental health among patients with psoriasis: A replication and extension study using BADBIR
SHD, 2022.Lada G, Chinoy H, Talbot PS, Warren RB, Kleyn CE; BADBIR Study Group.Read publication: SHD Related Contact Us Tel: +44 (0)161 306 1896 Email: badbir@manchester.ac.uk Find Us The University of ManchesterFirst Floor Bright...
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis
J Invest Dermatol, 2022.Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, Capon F, Chung R, Curtis CJ, Di Meglio P, Goulding JMR, Griffiths CEM, Lee SH, Mahil SK, Parslew R, Reynolds NJ, Shipman AR, Warren RB, Yiu ZZN, Simpson MA, Barker JN, Dand N,...
Ethics Progress Report: 2022
Read the 2022 Ethics Progress Report. Related Contact Us Tel: +44 (0)161 306 1896 Email: badbir@manchester.ac.uk Find Us The University of ManchesterFirst Floor Bright BuildingManchester Science ParkManchesterM15 6GZ Connect With...
Newsletter: 2022
Read our 2022 newsletter by downloading the printable newsletter here BADBIR Newsletter 2022 Related Contact Us Tel: +44 (0)161 306 1896 Email: badbir@manchester.ac.uk Find Us The University of ManchesterFirst Floor Bright...
Contact Us
Find Us
The University of Manchester
First Floor Bright Building
Manchester Science Park
Manchester
M15 6GZ
